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Peri-implant bone resorption after total joint arthroplasty is a key parameter in aseptic loosening. Implant wear debris and biomechanical
aspects have both been demonstrated to be part of the bone resorption process. However, neither of these two parameters has been clearly
identified as the primary initiator of peri-implant bone resorption. For the biomechanical parameters, micromotions were measured at the bone–
implant interface during normal gait cycles. The amplitude of the micromotions was shown to trigger differentiation of bone tissues. So far no data
exists directly quantifying the effect of micromotion and compression on human bone. We hypothesize that micromotion and compression at the
bone–implant interface may induce direct activation of bone resorption around the implant through osteoblasts–osteoclasts cell signaling in
human bone. This hypothesis was tested with an ex vivo loading system developed to stimulate trabecular bone cores and mimic the micromotions
arising at the bone–implant interface. Gene expression of RANKL, OPG, TGFB2, IFNG and CSF-1 was analyzed after no mechanical stimulation
(control), exposure to compression or exposure to micromotions. We observed an 8-fold upregulation of RANKL after exposure to micromotions,
and downregulation of OPG, IFNG and TGFB2. The RANKL:OPG ratio was upregulated 24-fold after micromotions. This suggests that the
micromotions arising at the bone–implant interface during normal gait cycles induce a bone resorption response after only 1 h, which occurs
before any wear debris particles enter the system.
© 2007 Elsevier Inc. All rights reserved.Keywords: Bone resorption; Orthopedic implant; Mechanical stimulation; Gene expression; MicromotionsIntroduction
After total joint arthroplasty, a radiolucent zone is frequently
observed at the interface between bone and implant [4,29]. This
radiolucent zone is associated with a progressive peri-implant
bone resorption. The implant fixation is affected, therefore
inducing a risk of aseptic loosening. This becomes a serious
problem as aseptic loosening accounts for more than two-third
of hip revisions in Sweden, a country where an extensive
implant register has been set up for many years [16].
Two hypotheses are generally used to explain peri-implant
bone resorption. The first hypothesis focuses on a biological
reaction to wear particles. Numerous studies have shown that
the debris after implant wear induces inflammatory reactions in⁎ Corresponding author. Fax: +41 21 693 86 60.
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doi:10.1016/j.bone.2007.09.055the tissues surrounding the implant [2,7]. Bone formation may
also be impaired by the presence of particles, such as titanium
debris which were shown to induce apoptosis to osteoblasts
culture in vitro [24]. In all cases, particulate debris accumulate
in the tissue surrounding the implant. Upon accumulation, a
chain of cellular events is triggered within the tissue leading to
periprosthetic osteolysis and implant loosening [15]. The
second hypothesis used to explain peri-implant bone resorption
is based on biomechanical considerations. A stiff metallic
implant in a load bearing bone considerably changes the
mechanical state of the bone. Based on a numerical approach,
Huiskes and Nunamaker showed that bone resorption around
the implant is associated with high peak stresses immediately
postoperatively [8]. The bone structure is affected by the new
stress patterns around an implant. Numerical models predict
bone loss around the implant based only on these modified
mechanical patterns [33].
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bone–implant interface. The pumping action of the implant
during gait cycle causes load fluctuation within the hip joint
fluid. Using a numerical model, the interfacial compressive
stress involved was found to be between 2×10−3 and 0.1 MPa
[27]. Beside compressive stress, micromotions at the interface
have been suspected to play a key role in tissue differentiation
around the implant. It has been calculated that micromotions
between 5 and 100 μm occur at the bone–hip implant interface
during normal gait cycles [27]. Mandell et al. analyzed the case
of conical-collared intramedullary hip stem and reported
micromotions up to 163 μm in the worst design [17]. From
an experimental point of view, Baleani et al. quantified bone–Fig. 1. Bone core extraction procedure: each femoral head was fixed axially with two
was extracted from the central section of the femoral head (B). Each bone core was e
extracted from the biopsy puncher and rinsed (D). Histogram distribution of patient
cores. No significant correlation was observed between age or sex and genetic expr
microstimulation device which was placed in a dedicated incubator during the 1 h me
micromotions on the top of the bone core. The device was controlled with an externimplant micromotions under torsional load with position
transducers in a hip implant model. A maximum of 56 μm
was measured in uncemented stems [1]. Finally, with in vivo
models, Jasty et al. found that micromotions lower than 40 μm
favor bone formation in dog, while micromotions higher than
100 μm lead to the creation of a fibrous tissue [10].
Based on clinical observations, numerical and experimental
biomechanical analysis and in vivo experiments, there is strong
evidence to support the theory that micromotions and
compressive stress at the bone–implant interface play an
important role in the process of peri-implant bone resorption.
However, so far no data exist quantifying directly the effect of
micromotion and compression on human bone. Therefore wescrews in a custom fixation device (A). Using a surgical saw, a 6 mm thick slice
xtracted manually from the slice with a biopsy puncher (C). The bone core was
age from which femoral head has been collected to process the cylindrical bone
ession following mechanical stimulation (E). The bone core was inserted in the
chanical stimulation. The upper part applied a 0.5 MPa compression and 100 μm
al computer (F).
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implant interface may induce direct activation of bone
resorption around the implant through osteoblasts–osteoclasts
cells signaling in human bone. This hypothesis was tested with
an ex vivo loading system using human bone samples.
Materials and methods
Bone samples preparation
Twenty-five human femoral heads were obtained from the Hôpital
Orthopédique de la Suisse Romande following total hip prosthesis procedures
(Ethical Protocol 51/01, University of Lausanne). In the next 4 h following the
sample collection, each femoral head was fixed axially in a custom fixation
device and a central section of 6 mm thick slice was extracted with a surgical
saw. Then, 4 to 16 trabecular bone cores of 3 mm radius and 6 mm height were
extracted from the slice with a biopsy puncher (Shoney Scientific, Pondicherry,
India) at 15 mm from the cortical bone layer (see Figs. 1A–D). The bone cores
were then incubated overnight in DMEM (Sigma, Buchs, Switzerland)
containing 10% of fetal bovine serum (Sigma) and 1% of PSF (100×,
10,000 U/ml penicillin, 10,000 μg/ml Strepzin, 25 μg/ml Fungizone)
(GibcoBRL, New York, USA) at 37 °C, 5% CO2, 90% H2O.
Initial gene expression level
Nine samples were used to control the initial gene expression level after
sample preparation. Three samples were collected immediately after punching,
three samples 24 h after punching and three samples 48 h after punching. These
nine samples were not mechanically stimulated but placed in 1 ml Trizol
(Invitrogen AG, Switzerland) and stored at −80 °C for later ribonucleic acid
(RNA) extraction.
Bone samples stimulation
A device was developed to apply combined compression and micromotions
mode on the surface of trabecular bone samples simulating then the mechanical
situation arising at the bone–implant interface [23]. Briefly, the device consists
of a bottom fixed and top moving plates with bone core placed in between (Fig.
1F). A 0.5 MPa compression was applied from top and sinusoidal micromotion
of 100 μm at a frequency of 1 Hz were applied on the top bone surface. As the
mechanical stimulation targeted micromotion and compression, a theoretical
evaluation of the loading modes was performed. A Finite Element Analysis was
then developed to evaluate the mechanical stimulation in the bone core
corresponding to the experimental boundary conditions. Because of the relativeFig. 2. A Finite Element Analysis provided an estimation of the octahedral normal and
were added to compression, normal strains did not changed, but shear strains increas
magnified by 20.low frequency and high porosity, the inertial and fluid effects were omitted in
this numerical study. The bone sample was assumed elastic, homogeneous and
isotropic, and the contact was assumed to follow a Coulomb friction law. The
elastic modulus was 250 MPa [19] and the bone–metal friction coefficient was
0.2 [14,28]. For the compression case, the volume average of the octahedral
normal and shear strains was respectively 286 and 1190 microstrains. When
micromotions were added to compression, normal strains were not affected, but
shear strains increased by 7% (Fig. 2).
The bone cores were separated randomly into three groups: control,
compression and micromotion. Bone cores from the control group were
incubated for 1 h at rest in 1 ml culture medium (control). Bone cores from the
compression group were incubated in 1 ml culture medium and a compression of
0.5 MPa was applied vertically on the sample in a special surgical steel chamber
during 1 h (compression). Bone cores from the micromotion group were
incubated in 1 ml culture medium. A 0.5 MPa compression was applied from top
and sinusoidal micromotion of 100 μm at a frequency of 1 Hz were applied on
the top surface during 1 h (micromotion). The parameters of the sample
stimulations were chosen according to the results of previous numerical studies
performed in our laboratory [27] and corresponded to a normal load during gait
cycles.
RNA extraction
Immediately after the stimulations, each sample was placed in individual
tube containing 1 ml Trizol and stored at −80 °C. The bone samples were mixed
with a stainless steel bead (QIAGEN GmbH, Germany) deposited in each tube
by shaking the tubes three times in the MM300 Mixer Mill (Retsch GmbH and
Co, Hann, Germany) at 30 Hz during 30 s. Then, 0.2 ml of chloroform (Sigma-
Aldrich, Switzerland) was added to the homogenate. The tubes were shaked
manually, and after phase separation, 0.5 ml of the upper phase was transferred
in new tubes where 0.5 ml of ice-cold isopropanol (Sigma-Aldrich) was added.
Tubes were vortexed and stored overnight at −80 °C. RNA was isolated and
purified with NucleoSpin columns (Macherey-Nagel, Düren, Germany)
according to the protocol furnished by the manufacturer. The concentration
and quality of the extracted RNA were measured with a biophotometer
(Eppendorf AG, Germany). RNA integrity was verified by optical density (OD)
absorption ratio A260/280 nm. OD between 1.7 and 2.2 was chosen as a quality
criteria for inclusion (adapted from Cambridge Systems Biology Centre,
Cambridge, UK). RNA was eluted in 40 μl of RNase-free water and stored at
−80 °C until further processing.
First strand synthesis
For each sample, 5 μl of total RNA was reverse-transcribed using the
Taqman Universal polymerase chain reaction (PCR) reagents with random
hexamers (Applied Biosystems, Foster City, CA). Reaction volumes were fixedshear strains, for the compression and micromotions cases. When micromotions
ed by 7%. For illustration purpose, the deformation of the finite element mesh is
Fig. 3. Relative gene expression of TGFB2, OPG and RANKL quantified by RT-
PCR after 0, 24 and 48 h of incubation. The results are shown as 2−ΔΔCT values
and plotted as mean±SEM of each individual experiment.
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PCT-0100 (MJ Research, Waltham, MA) was programmed as follows: 25 °C
10 min, 48 °C 30 min, and 95 °C 5 min.
Quantitative polymerase chain reaction (qPCR)
The following gene expressions were quantified: RANK ligand (RANKL),
osteoprotegerin (OPG), interferon-gamma (IFNG), colony stimulating factor 1
(CSF-1) and transforming growth factor beta2 (TGFB2) as target genes and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as non-regulated refer-
ence gene (housekeeping gene).
Specific primers for each gene were designed with the Primer Express®
software (Applied Biosystems) and purchased from Integrated DNA Technol-
ogies (Coralville, IA). An additional sequence of 18 bp was added to the 5′ end
of every forward primer to use the Amplifluor Universal Detection System
(Intergen Discovery Products, Purchase, NY). PCR reactions were performed in
25 μl:5 μl of first strand, 12.5 μl of TaqMan Universal PCR Master Mix
(Applied Biosystems), and 7.5 μl of the primers working solution. Thermal
cycle conditions were 50 °C 2 min, 95 °C 10 min, then 50 cycles at 95 °C 15 s,
60 °C 1 min. Amplifications were monitored with the ABI Prism 7700 (Applied
Biosystems). Measurements were performed in duplicates.
Gene expression analysis and statistics
The threshold cycle CT was measured for each gene and each sample from
the PCR amplification curve with a standard routine. CT table was analyzed for
each gene in each experiment: if duplicates from one cDNA presented a
difference larger than 3 cycles (due to experimental artifacts such as limited
pipetting precision, presence of bubble in the well, etc.), the measure was
dismissed; otherwise CT was calculated as the duplicate mean. If CT was greater
than 35 cycles, the measure was dismissed.
Relative gene expressions were calculated with the 2−ΔΔCT method [22]
with GAPDH as housekeeping gene. As the level of GAPDH expression may be
influenced by the mechanical stimulation and consequently would render invalid
its use as reference gene, in a pilot study we normalized the GAPDH expression
by the level of 18S expression. No effect of mechanical stimulation was
observed on GAPDH expression (data not shown). Unless 18S is similarly
regulated as GAPDH through mechanical stimulation, which seems to be
unlikely, GAPDH gene expression can be used as a stable reference gene in this
experiment. We used a randomization of the differences and one-way ANOVA
to compare the gene expressions of the different groups [6]. All values were then
normalized to the expression of the control group. All mathematical operations
and statistical analysis were performed using Mathematica® (Wolfram
Research, Inc. USA). A p-value lower than 0.05 was considered significant
while p-value lower than 0.1 was considered as a strong trend.
Results
In the following results, we report normalized gene
expressions as mean±standard error of the mean (SEM).
Sample collection
The bone core samples were obtained from femoral heads
of male and female patients between 50 and 80 years old
(Fig. 1E). No significant correlation was observed between
age or sex and genetic expression. Table 1 summarizes the
number of cylindrical cores in each group. One hundred andTable 1
Number of bone cores used for each condition
# of bone cores Control Compression Micromotion
112 62 20 30twelve samples were used in the main experiment. Fifty-four
samples passed the quality criteria (A260/A280) and were
used for normalized gene expression analysis comparison
between control, compression and micromotion regimen.
Initial gene expression level
As the process of bone core extraction may affect the gene
expression of the sample, nine samples were used to evaluate
the initial and 24 h gene expressions level after samples prep-
aration and compare it to the value obtained 48 h after sample
preparation. Immediately after sample punching, gene expres-
sions were the following: RANKL 0.68±0.25, OPG 1.5±0.7,
TGFβ 3.2±0.7 compared to the 48 h values. After 24 h,
the expressions were: RANKL 0.5±0.2, OPG 0.6±0.2, TGFβ
0.9±0.2 compared to the 48 h values. Finally, after 48 h, when
we compare the values between each sample, the expressions
became: RANKL 1.4±0.5, OPG 0.77±0.12, TGFβ 1.0±0.2
(Fig. 3). None of the expressions at 48 h was significantly
different from one, meaning that the gene expression of all core
samples was similar. None of the expression levels at 24 h was
significantly different from those at 48 h. The variance of the
expression levels was significantly different than those
immediately after punching. These results suggest that, after 1
or 2 days of incubation, the pool of bone samples is in a
homogenous state of genetic expression at least for the tested
genes. All the samples were then incubated 24 h after extraction
prior to the 1 h mechanical test.
Gene expression according to the mechanical stimulus
The relative gene expression for the selected genes and
mechanical stimulations are presented in Fig. 4. RANKL
expression was upregulated 2.8±0.9-fold in the compression
group and upregulated 8±2.8-fold in the micromotion group
when compared to control. The differences between compres-
sion and control, and between micromotion and control were
significant, whereas there was a strong trend suggesting that the
expression level between micromotion and compression was
different.
Fig. 4. Relative gene expression of RANKL, OPG, IFNG, TGFB2 and RANKL:OPG expression ratio quantified by RT-PCR after 1 h of incubation (control), 1 h
of 0.5 MPa compression or 1 h of 0.5 MPa compression+100 μmmicromotion (micromotion). The results are shown as 2−ΔΔCT values and plotted as mean±SEM of
each individual experiment. Symbols: ⁎ (pb0.05 vs. control), + (pb0.05 vs. compression), ⋆ (trend at pb0.1 level vs. control), † (trend at pb0.1 level vs.
compression).
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0.02-fold in the compression group and downregulated 0.34±
0.07-fold in the micromotion group when compared to
control. The differences between compression and control,
micromotion and control, and micromotion and compression
were significant.
TGFB2 expression was downregulated 0.3±0.1-fold in the
compression group and downregulated 0.2±0.08-fold in the
micromotion group when compared to control. The difference
between compression and control and micromotion and control
was not significant but the p-value (p=0.08) suggested a strong
trend towards significant differences.
IFNG expression was not significantly changed in the
compression group (1.4±0.4) and was downregulated 0.29±
0.05-fold in the micromotion group when compared to control.
The differences between micromotion and control and micro-
motion and compression were significant.
CSF-1 was not significantly affected in the compression
group (1±0.5) nor in the micromotion group (1±0.5) when
compared to the control group.
Discussion
A clinical study showed that up to 14% bone loss arose
during the first 3 months after total hip arthroplasties [34]. In
parallel, rapid early migrations have been detected by roentgen
stereophotogrammetry in many asymptotic hips, often as earlyas 4 months postoperatively [11,18]. The migrations have been
found to predict an increased risk of clinical loosening. The fate
of an orthopedic implant seems then to be determined at an early
stage, probably before any wear particles are produced, and is
certainly related to mechanical factors. Micromotion at the
bone–implant interface could then be considered as good
candidates to explain peri-implant bone resorption and was
indeed identified as key players in animal studies.
However, no information has so far confirmed these results
for human bone as the only information available is based on
tissue retrieval obtained from failed implants, the last stage of
the degeneration process [31]. Based on a original ex vivo
approach, the present study evaluates the micromotion effect on
bone resorption for human samples and verifies if resorption
could be initiated immediately after surgery, when no wear
particles are part of the process.
We hypothesized that micromotions could induce an upregula-
tion of genes involved in osteoclastic bone resorption. Therefore,
we analyzed the expression ratios of the RANKL/OPG signaling
system, as well as the expression ratios of TGFB2, IFNG and
CSF-1. We used a control group, a compression group and a
micromotion group, mimicking the situation arising around
femoral stems of hip implants during gait cycles [27].
RANKL is a critical factor for late stage osteoclasts differ-
entiation and activation. RANKL was shown to be expressed
by osteoblasts after mechanical or hormonal stimulations [26].
OPG, the decoy receptor of RANKL produced by osteoblasts, is
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[30]. Our results show that micromotion and compression
dramatically increase RANKL expression suggesting that the
number and the activity of osteoclasts at the surrounding
implant is increased by micromotion and compression in normal
gait conditions. We also observed a downregulation of OPG
expression after exposition to compression alone or to micro-
motion suggesting that the balancing effect of RANKL byOPG is
decreased.
Experimental and mathematical evidences have recently
shown that OPG and RANKL expressions are regulated in-
versely in osteoblasts and that bone remodeling rate is probably
determined by the RANKL:OPG ratio [3,12,13]. Our results are
in concordance with these observations: RANKL and OPG are
expressed inversely after exposition to compression alone or
after compression and micromotion, as discussed previously.
We observed that the RANKL:OPG ratio is significantly
increased ten-fold by compression and significantly more than
twenty-fold by compression and micromotion, suggesting that
micromotions are potent activators of high bone turnover rate.
Our observations on the regulation of RANKL/OPG by
compression and micromotions suggest that the number of
osteoclasts is enhanced, and bone turnover rate is increased in
the periprosthetic area with normal gait cycle conditions. This
might be one of the causes of the observed bone resorption
around orthopedic implants.
Osteoclasts and osteoblasts activities are strongly correlated in
vivo, and an increased osteoclastic activity might induce an
osteoblastic response. Similarly, micromotion may affect osteo-
blastic recruitment. Therefore we also analyzed the expression of
bone formation signaling molecules such as TGFB2 and IFNG.
TGFB2 is expressed by osteoblasts and has contrasting effects on
osteoblasts and osteoclasts. TGFB2 is a bone formation
promoting molecule operating through chemotactic attraction of
osteoblasts and enhancement of osteoblasts proliferation at the
early stages of differentiation [9]. In cell culture, IFNGwas shown
to inhibit osteoblastic cell function [5] and potently inhibit
osteoclasts formation. In bone explants, it inhibits osteoclasts
differentiation [32]. We observed a downregulation of TGFB2
after exposure to compression alone and after compression plus
micromotion, suggesting that micromotion at the implant
interface does not increase recruitment of osteoblasts through
TGFB2 signaling. TGFB2 was shown to be a promoter of
osteoclasts formation by increasing the sensitivity of progenitors
to RANKL (through upregulation of RANK in preosteoclastic
cells) [25,35]. TGFB2 can also inhibit osteoclasts formation
through a downregulation of the RANKL:OPG ratio [35]. In our
analysis, RANKL:OPG is increased while TGFβ is decreased
which is concordant. Our measures show that compression and
micromotion decrease IFNG expression by two thirds. The
consequence is then difficult to interpret in the peri-implant
situation as the effect could be either a decrease of bone formation
through inhibition of osteoblastic function or a decrease of bone
resorption through inhibition of osteoclastic differentiation.
Further studies are needed to clarify the role of this molecule.
The aim of the experimental setup used here was to simulate
the mechanical situation at bone–implant interfaces using exvivo bone samples. The amplitudes of the applied compression
and micromotion were set to measured or calculated values. The
main drawback of the experimental set-up was the unknown
consequence of preparation procedures and ex vivo incubation
on bone cell function. We however showed that at least there is
an initial homogeneous level of gene expression between
samples. We can then assume that we have a consistency of
initial conditions in our experiment. However, certainly due to
the inherent biological variability, we obtained variable quality
of extracted RNA, which may affect the gene expression
quantification. It has to be mentioned that quantification of gene
expression is only one part of the biological reaction to me-
chanical stimulus due to possible different post-transcriptional
events. However, to our knowledge, no other experimental
design allows one to study the effect of micromotion on the
bone–implant interface with living human samples. These
challenging technical difficulties were solved by a posteriori
controls of RNA quality and variability of gene expression
duplicates. More than 50% of the samples were discarded
during these control procedures. It implied that paired-control
statistical designs could not be use and that a large number of
samples had to be processed to overcome the inter-specimen
variations and to observe significant differences in the gene
expression.
To conclude, our results suggest that micromotion at the
bone–implant interface during normal gait cycles induce a rapid
bone resorption response after only 1 h, which occurs before
any wear debris particles could enter the system. These results
confirm our initial hypothesis.
Based on these results, we proposed that blocking locally the
osteoclastic resorption through the action of bisphosphonate
may prevent the peri-implant osteolysis. The first results of our
animal model of implants used as bisphosphonate delivery
systems tend to confirm this idea [20,21].
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